Copycats - The Only Cats Who Know Where AstraZeneca's At

Everyone wants to be a copycat these days. That's why UK-listed healthcare giant AstraZ is taking steps to guard against generic drug makers stealing its pharma-making thunder. It is agreed with Teva a deal that will stop Teva selling copycat versions of heartburn drug Nexium, at least for now. The Nexium patent ceases-to-be in 2014.